NCT00190723View on ClinicalTrials.gov

A Study of LY317615 in Patients With Brain Tumors

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

December 31, 2006

Conditions

Malignant Glioma

Interventions

DRUG

Enzastaurin

Trial Locations (1)

20892

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Bethesda

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00190723 - A Study of LY317615 in Patients With Brain Tumors | Biotech Hunter | Biotech Hunter